Clinical Trial Update: A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population

View source ↗

Summary

AstraZeneca-sponsored translational clinical trial in Chinese individuals aims to predict COPD biomarkers and identify phenotypes and endotypes, as well as earl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Status: RECRUITING